2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Core Insights - The healthcare sector is characterized by high competition, regulation, and technical complexity, making it advisable for most investors to focus on larger companies within the industry [1] Group 1: Industry Overview - The healthcare sector often sees mergers and acquisitions, with larger companies acquiring innovations from smaller firms [2] - The regulatory burden in healthcare is significant, requiring substantial financial resources and time for new treatments to gain approval, which smaller companies often struggle to manage [3] - Post-approval, marketing a product demands considerable spending, which larger companies are better equipped to handle compared to smaller firms [4] Group 2: Company Analysis - Medtronic, with a market capitalization of $120 billion, is a leading medical device manufacturer known for its attractive dividend yield and long history of dividend growth [5][6] - Pfizer, valued at $145 billion, is a major pharmaceutical company actively working to rebuild its drug pipeline, making it a strong choice for long-term investors [5][7] - Medtronic's dividend yield is approximately 3%, with a history of 48 consecutive years of dividend increases, positioning it close to becoming a Dividend King [8]